by DRG International | Jul 16, 2020 | News, Products |
DRG is proud to announce the launch of two new Anti-Müllerian Hormone (AMH) assays: AMH ELISA (EIA-6141) AMH DRG HYBRiD XL® (HYE-5770) Clinical Application: AMH has been identified as a reliable marker of ovarian reserve that can help predict early ovarian...
by DRG International | May 25, 2020 | News |
Sales and Business Development Manager, North America Our Company DRG International, Inc. (DRG) is a specialty diagnostic and medical device equipment manufacturer and distributor founded in 1970. The company is privately held and headquartered in central New Jersey...
by DRG International | May 15, 2020 | News |
Hepcidin Proficiency Test On April 30th, 2020, we received the final report of the first ever Hepcidin Proficiency Test. This study has being organized by Radboud University Medical Center (in Nijmegen, The Netherlands) in collaboration with SKML (the Dutch Foundation...
by DRG International | May 15, 2020 | News |
DRG Awarded with “Innovative Through Research” Seal of Approval The Stifterverband für die Deutsche Wissenschaft honours the research activities of DRG Instruments GmbH with the seal of approval “Innovative Through Research.” The Stifterverband...
by DRG International | May 1, 2020 | News, Products |
Can hepcidin be a useful marker in the diagnosis and monitoring of De Quervain thyroiditis? Endocrine Abstracts (2019) 63 GP182 | DOI: 10.1530/endoabs.63.GP182Dorota Filipowicz, Aleksandra Hernik, Ewelina Szczepanek-Parulska & Marek Ruchała Author affiliations...
